it is so hard to watch day-in and day-out to see a good company being demolished by god chosen people.. why don't they pull in the launch day if they have enough inventory to supply to N patients ???
I used to own MAKO which manufacturing Robotic Surgical devices.. WS pumped 2 years prior, drove stock up to about $40ish, then short the heck out of it until it drops below $10.. company needed cash to operate, so they sold for 3X at the trading price which is $30.. well below the highest price 2 years prior to M&A... similar trading pattern with MNKD, they drove stock price to the ground and keep it there until the good news hit the wire..
it is ready but couldn't blast off as expected.... sooner is better... MNKD should put out a PR stating which insurance cos are covering Affrezza... if this don't discourage shorts to exit, then nothing will.. GL
not clear on 2015 sale projects: Initial 3- line capacity implies 400M units, which could equate to ~$350–450M annually in sales based on the conservative pricing and usage assumptions in our current model. We forecast 2015 sales of $46M at this time.
It sounds like MNKD won't launch until Dec 2015 to forecast $46M revenues for 2015..
colton, Oh, did they hurt your feewins by not inviting you ??? they're so sowwy...
for the record, are you long, short or you have no money to invest so you are just practicing to be an aszhole ?
I hate to be negative, if someone bought 636,000 shares, that mean someone else was selling those shares to them , is that right ?
there must be some kind of dark pool transactions that brokage firms reconciled AH.. prices already set in private transactions.. I didn't see 2.1M shares on L2 .. if shorts cover with 2.1 mil share AH, price should move up at least $1 because lack of sellers... just sayin'..
and WS is the collection of this scam.. IRA, 401k, pension plans and SS system will be stolen by these basters...most of the US workers worked hard all of their lives, and they have saved up, but at the end, most of them won't have enough money to retired on.. they hit a reset button periodically (every 10-20yrs) to transfer funds from public to privately owned accounts.. wake up people... GL
Many bio-techs companies have used "bait and switch" tactic by comparing themselves with successful companies to lure investors to buy in.. by comparing CLDX with AMGEN and Genetech, is not far from this tactic.. go tell investors who paid $24.50 in secondary last year and see how are their ROI ?
Since you're not answered the basic questions, simply because your investment style is expecting "black swan" event.. speculate, hope and pray... keep pumping long enough and, the perception will became your reality..GL on that..
instead of correcting my statement, why don't you correct the market which shown the skeptic about the CLDX potential ... stock price don't drop 50% or short has increased 100% in less than 6 months for no reason... pumpers keep crying for under valued, stock manipulation, company is worth more than a year ago when it was traded at $38/shr, pipeline is getting longer and longer, M&A is the logical choice, .. and the stock price is going lower and lower..
ask yourself this question: as a retail investor, should you bet with the smart money or should you bet by over-inflating the value of a company to justify your believe.. CLDX has no data to support the investment fundamentals, no financial results that validating the science and no reputable analyst would projected the timelines and risk/reward analysis on each drug .. all the unknown analysts who have upgraded the CLDX past year have been wrong, and none of them would be accountable for their wrongness. In fact, many of them may have shorted the stock while raising the price target.. GL
Only 1 out of every 25 drugs that go into human trials ,under $40 is not being pursued by Celldex, The process for FDA is risky and long, investors are not going to be able to demand financial results until the FDA approves.. blah, blah, blah... so, as long as CLDX not getting an FDA approval, investors should not demand financial results ??? after 30 yrs in business, CLDX has not gotten a single FDA approval, and many clinical trials have been completed but yet produced a single $ in revenues... every company is in business to make money, not to run experiment for over 30 years and produced nothing.. wake up people..
tpatten, you need to answer 4 questions before trying to correct my statement:
1. How long has CLDX being in cancer cure researching business ?
2. How may FDA approval has CLDX got ?
3. Which drug is (was, will be) the first FDA approval, when (timelines) and projected revenues ?
4. how many CLDX clinical trials completed without producing an FDA approval ?
if you can't answer above questions , then stop shooting off your mouth without knowing all the facts. CLDX has known to creating a lot of lighting and thunders, but it has produced no rain.
FF, since you enjoy waterboarding so much, give me your address, I will send Tony to pick you up for Waterboarding enhanced entertainment (Wee...)
that is an indicative of NOT focusing to get one platform or one drug that validating by the FDA.. these researchers treated CLDX as a junior college labs that they just run one experiment after another without producing anything that could monetizing their efforts.. it is time for investors to demand financial results, not keep inventing clinical trials quarter after quarter.. their effort is an incremental improvement, not a revolutionary "game changer" as they have marketed ..